发明名称 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-£2-(PIPERIDIN-1-YL)ETHOXY|-PHENOXY)-2-(4-METHOXYPHENYL)BENZO£B| THIOPHENE HYDROCHLORIDE
摘要 PURPOSE: To obtain the subject crystal form having an X-ray diffraction pattern including specific peaks, being a nonsteroidal mixed estrogen antagonist/agonist useful for reducing serum cholesterol and preventing hyperadiposis, osteoporosis, an estrogen-dependent cancer such as breast cancer, etc. CONSTITUTION: A crystalline 6-hydroxy-3-(4-£2-(piperidin-1-yl) ethoxy|phenoxy)-2-(4-methoxyphenyl)benzo£b|thiophene hydrochloride(arzoxifene) has an X-ray diffraction pattern including peaks at 2&thgr;=4.6±0.2, 7.8±0.2, 9.3±0.2, 14.0±0.2, 17.6±0.2, 20.8±0.2 and 24.3±0.2 (in the case of obtaining these data from a copper radiation source at 25±2 deg.C at 35±10 %; relative humidity). The compound can be produced and isolated at a room temperature, for example, by crystallizing arzoxifene from a mixed solution of isopropyl alcohol and water.
申请公布号 KR20010049911(A) 申请公布日期 2001.06.15
申请号 KR20000043586 申请日期 2000.07.28
申请人 ELI LILLY AND COMPANY 发明人 BUSH JULIE KAY;CONRAD PRESTON CHARLES;FLOM MERLYN GERARD
分类号 C07D409/12;A61K31/4433;A61K31/445;A61K31/4535;A61K31/565;A61K35/22;A61K38/09;A61P3/06;A61P5/32;A61P9/00;A61P13/08;A61P15/00;A61P19/00;A61P19/10;A61P25/00;A61P25/28;A61P35/00;C07D333/64;(IPC1-7):C07D409/12 主分类号 C07D409/12
代理机构 代理人
主权项
地址